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Edited by Felix WielandAbstract ABCA3 is proposed to function as a lung surfactant
lipid transporter. Here we report ABCA3-dependent lipid uptake
into intracellular vesicles in lung adenocarcinoma A549 cells.
A549 cells stably expressing GFP-tagged wild-type ABCA3
(A549/ABCA3WT) had larger LAMP3-positive vesicles than
their parental cells as well as A549 cells expressing a Walker
A motif mutant (A549/ABCA3N568D). The choline-phospholipids
level in A549/ABCA3WT was increased 1.25-fold compared to
that in A549 and A549/ABCA3N568D cells, while the cholesterol
levels were similar. Sucrose gradient fractionation analysis
in A549/ABCA3WT cells revealed that choline-phospholipids
were enriched in low-density and nile red-positive vesicles. Elec-
tronmicroscopic analysis showed multilamellar vesicles in
A549/ABCA3WT cells. These results indicate that ABCA3 medi-
ates ATP-dependent choline-phospholipids uptake into intracel-
lular vesicles.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Lamellar body1. Introduction
The family of ATP-binding cassette (ABC) transporters is
one of the largest gene families, and is involved in ATP-depen-
dent transport of a variety of substrates across membrane [1].
The ABCA subfamily is unique in that its members have two
large extracellular domains and it is particularly involved in
the transport of lipids [2]. ABCA1 and ABCA7 localize mainly
to the plasma membrane and mediate lipid eﬄux from cells
[3,4], while ABCA3 and ABCA12 localize mainly to intracellu-
lar compartments and are suggested to mediate storage of sur-Abbreviations: ABC, ATP-binding cassette; GFP, green ﬂuorescent
protein; PNS, post-nuclear supernatant; SP, surfactant protein
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doi:10.1016/j.febslet.2007.05.078factant lipid and ceramide, respectively, within intracellular
organelles [5–7].
The lipid transport function of some ABCA transporters has
been investigated using in vitro culture systems. The expression
of ABCA1 and ABCA7 in cultured cells promotes phospholip-
ids and/or cholesterol release from the cells in the presence of
lipid-free apolipoprotein A-I in the culture medium [8,9]. On
the other hand, the mechanism of lipid uptake into intracellu-
lar compartments mediated by ABCA3 and ABCA12 are yet
unknown, as there is presently no practical method to investi-
gate lipid transport mediated by ABC transporters within
intracellular compartments.
In the present study, GFP-tagged wild-type and mutant
ABCA3 proteins were stably expressed in lung adenocarci-
noma A549 cells. Confocal microscopy, electronmicroscopy,
and lipid analysis together with sucrose gradient fractionation
revealed that ABCA3 mediates choline-phospholipids uptake
into intracellular vesicles. This approach also may be used in
determining the transport function of other ABCA transport-
ers involved in lipid storage into intracellular compartments,
such as ABCA12.2. Materials and methods
2.1. Establishment of stable cell line
A549 cells stably expressing GFP-tagged Walker A motif mutant
(N568D) ABCA3 protein (ABCA3-GFP) were established as previ-
ously described [10]. The expression of ABCA3-GFP proteins was
examined by immunoblot analysis and confocal microscopy.
2.2. Immunocytochemistry and lipid staining
A549 cells and derivative cells were ﬁxed and labeled with mouse
anti-human LAMP3 antibody (Chemicon) and Cy3-conjugated sheep
anti-mouse IgG antibody (Amersham). The cells were viewed with a
Zeiss confocal microscope LSM510-META. A ﬁxed threshold was ap-
plied to each of the ten confocal images by using Image J software, and
the LAMP3-positive area per cell was quantiﬁed. Statistical analysis
was performed by Bonferroni/Dunn procedure for post hoc testing.
2.3. Subcellular fractionation
Conﬂuent cells (ﬁve 100-mm dishes) were harvested and disrupted in
20 mM Tris–HCl (pH 7.3) buﬀer containing 1 M sucrose and complete
protease inhibitor mixture (Roche Applied Science) by N2 cavitation,
followed by centrifugation at 1000 · g for 10 min to obtain post-nucle-
ar supernatant (PNS). Mouse lung was homogenized by a Potter-El-
vehjem homogenizer, and PNS was obtained similarly. The protein
concentration was determined using Protein Assay Reagent (Bio
Rad) and bovine serum albumin as a standard. PNS was used forblished by Elsevier B.V. All rights reserved.
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lier [11]. A sucrose gradient consisting of 1 ml each of 0.8, 0.7, 0.6, 0.5,
0.4, and 0.3 M sucrose and 0.5 ml of 0.2 M sucrose was layered succes-
sively above 3.5 ml of PNS of cells (2 mg of protein) or PNS of lung
(4 mg of protein). The gradient was spun in a P40ST rotor (HITACHI)
at 125 · g for 15 min and then at 80000 · g for 3 h. After centrifuga-
tion, 1 ml of each fraction was collected from the top. For nile red-
staining, 5 ll of fraction 3 was mixed with an equal volume of
0.2 lg/ml nile red (Sigma) in phosphate-buﬀered saline and viewed
with a confocal microscope.
2.4. Immunoblot analysis
Immunoblotting was performed with the following antibodies: anti-
ABCA3 [12], anti-GFP (Santa Cruz), anti-LAMP3, anti-GRP78 (San-
ta Cruz), anti-pro-surfactant protein B (anti-proSP-B) (Santa Cruz), or
anti-surfactant protein C (anti-SP-C) (Santa Cruz). Anti-mature sur-
factant protein B antibody was provided by Dr. Yoshio Kuroki (Sap-
poro Medical University School of Medicine).
2.5. Lipids analysis
Total lipids in PNS and sucrose gradient fractions were extracted by
the method of Bligh and Dyer [13]. The amount of total cholesterol
and choline-phospholipids was measured using enzymatic assay kit
(Kyowa medex and Wako, respectively). Data normalized by the pro-Fig. 1. Expression of wild-type and N568D ABCA3-GFP in A549 cells. (A)
and GRP78 in A549, A549/ABCA3WT, and A549/ABCA3N568D cells. (B) GF
and h) in A549 (a–c), A549/ABCA3WT (d–f), and A549/ABCA3N568D (g–i)
shown in (c), (f), and (i). The scale bar represents 10 lm. (C) LAMP3-positive
A549. N.S., not signiﬁcant.tein content are represented by means ± S.D. and statistical analysis
was performed as described above. For thin-layer chromatography
analysis, total lipids were developed with chloroform–methanol–petro-
leum ether–acetic acid–boric acid 40:20:30:10:1.8 (v/v/v/v/w) [14] and
visualized with 10% (w/v) copper sulfate in 8% (w/v) phosphoric acid.
2.6. Electronmicroscopy
A549 cells and derivative cells were ﬁxed for 30 min at room temper-
ature in 0.1 M cacodylate buﬀer (pH 7.4) containing 2.5% glutaralde-
hyde and 2 mM CaCl2, post-ﬁxed in 1% osmium tetroxide, dehydraded
in ethanols, and embedded in EPON 812 resin. Ultrathin sections were
cut with an ultramicrotome, stained with uranyl acetate and lead cit-
rate, and observed with an electron microscope at 80 kV (Hitachi,
H-7650).3. Results
3.1. Expression of wild-type ABCA3-GFP enlarges LAMP3-
positive vesicles in A549 cells
We previously established lung adenocarcinoma A549/AB-
CA3WT cells, which stably express GFP-tagged wild-typeImmunoblot analysis of the level of ABCA3-GFP, LAMP3, proSP-C,
P ﬂuorescence (a, d, and g) and immunoﬂuorescence of LAMP3 (b, e,
cells. Nuclei were counterstained by DAPI, and merged pictures are
area per cell was quantiﬁed by using Image J software. *P < 0.01 versus
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expression plasmid of ABCA3 containing naturally occurring
mutation N568D in the Walker A motif, which exhibits im-
paired ATP-binding and ATP-hydrolysis activities [10], was
transfected in A549 cells to generate A549/ABCA3N568D cells.
Immunoblot analysis using anti-GFP antibody showed that
the expression level of ABCA3-GFP in A549/ABCA3N568D
cells was comparable to that in A549/ABCA3WT cells
(Fig. 1A). The GFP-positive vesicles in A549/ABCA3WT cells
(Fig. 1B, panel d) appeared to be larger than those in A549/
ABCA3N568D cells (panel g). In A549/ABCA3WT cells, ﬂuores-
cence signals of LAMP3, a marker of multivesicular bodies
and lamellar bodies [15,16], were detected mainly at GFP-ﬂuo-
rescence-positive vesicles (Fig. 1B, panels e and f), and the
LAMP3-positive area was larger than those in A549 and
A549/ABCA3N568D cells (Fig. 1B, panels b and h, and
Fig. 1C). Immunoblot analysis showed an increased level of
LAMP3 in A549/ABCA3WT cells compared to those in A549
and A549/ABCA3N568D cells (Fig. 1A). On the other hand,
the levels of pro-surfactant protein C (proSP-C), which local-
izes to the endoplasmic reticulum and Golgi apparatus [17],
were similar in the three cell lines (Fig. 1A), and mature SP-
C was not detected (data not shown). GRP78, a marker of
endoplasmic reticulum, was similar in the three cell lines
(Fig. 1A). These results indicate that expression of ABCA3-
GFP increases the LAMP3 level and enlarges LAMP3-positive
vesicles in A549 cells.
3.2. Expression of wild-type ABCA3-GFP increases choline-
phospholipids level but not cholesterol level in A549 cells
Surfactant lipids stored in lamellar bodies of alveolar type II
cells contain a large amount of phospholipids, mainly
phosphatidylcholine and phosphatidylglycerol (approximately
80% and 10% of total phospholipids, respectively) and choles-
terol (approximately 10% of total lipids) [18]. In A549 cells,
phosphatidylcholine was the most abundant phospholipid
(approximately 60% of total phospholipids), while phosphati-
dylethanolamine comprised approximately 25% and phospha-
tidylserine, phosphatidylinositol, and sphingomyelin wereFig. 2. The content of choline-phospholipids and cholesterol in PNS
of A549, A549/ABCA3WT, and A549/ABCA3N568D cells. (A) The
content of choline-phospholipids in PNS of each cell type is shown. (B)
The content of total cholesterol in PNS of each cell type is shown. Data
are represented as means ± S.D. (n = 3–4). *P < 0.05 versus A549.
N.S., not signiﬁcant.present in small amounts and phosphatidylglycerol was unde-
tectable (data not shown). Thus, we analyzed the contents of
choline-phospholipids and cholesterol in all three cell lines
by enzymatic colorimetric method. In A549/ABCA3WT cells,
the level of choline-phospholipids was signiﬁcantly increased
1.25-fold compared to that in A549 cells (Fig. 2A). In A549/
ABCA3N568D cells, the level of choline-phospholipids was sim-
ilar to that in A549 cells. The levels of total cholesterol were
similar in the three cell lines (Fig. 2B). These results indicate
that the expression level of wild-type ABCA3-GFP increases
the choline-phospholipids level but not the cholesterol level
in A549 cells.3.3. Expression of wild-type ABCA3-GFP increases low-density,
nile red-positive and choline-phospholipids-rich vesicles in
A549 cells
To determine in which intracellular compartments the con-
tent of choline-phospholipids is increased in A549/ABCA3WT
cells, sucrose gradient fractionation was performed. Analysis
of PNS from adult mice lung indicated that ABCA3 protein
was detected mainly in fraction 10 and partly in fractions 4–
9, and that GRP78 was detected in fractions 7–10 (Fig. 3B).
Low-density fractions 3–5 contained approximately 50–
60 nmol/fraction of choline-phospholipids (shown by closed
circle) and <10 nmol/fraction of cholesterol (shown by open
circle) (Fig. 3A). Mature SP-C was detected in fractions 3–5
(Fig. 3B). When fraction 3 was stained with nile red, which
is used to stain phospholipids in lamellar bodies [19], nile
red-positive vesicles (approximately 1 lm in diameter) were
clearly observed (Fig. 3A, inset). These results indicate that
mature lamellar bodies migrate to fractions 3–5 in this gradient
system, and that they are readily distinguished from endoplas-
mic reticulum components.
In A549 cells (Fig. 3C, left panel), fractions 3–5 contained a
small amount of choline-phospholipids (10 nmol/fraction or
less) and fraction 3 was nile red-negative (inset), suggesting
the absence of mature lamellar bodies. In A549/ABCA3WT
cells (Fig. 3C, middle panel), fractions 3–5 contained increased
choline-phospholipids (>30 nmol/fraction) compared to A549
cells, and fraction 3 was nile-red positive (inset). Thin-layer
chromatography analysis showed that in fraction 3 of A549/
ABCA3WT cells, phosphatidylcholine was mainly detected,
and phosphatidylethanolamine, phosphatidylinositol, and
sphingomyelin were present in small amounts (Fig. 3E). In
A549/ABCA3N568D cells (Fig. 3C, right panel), fractions 3–5
contained decreased choline-phospholipids (<20 nmol/frac-
tion) compared to A549/ABCA3WT cells (middle panel). On
the other hand, the distribution of cholesterol content in the
three cell lines was similar (Fig. 3C). These results indicate a
role of ABCA3 in choline-phospholipids uptake into intracel-
lular vesicles.
In A549 and A549/ABCA3N568D cells (Fig. 3D, left and right
panels), LAMP3 was detected mainly in fraction 10 and partly
in fractions 7–9, while in A549/ABCA3WT cells (middle panel)
LAMP3 was detected in fractions 7–10 as well as in lower-den-
sity fractions 3–6, distribution similar to that of ABCA3-GFP.
On the other hand, the distributions of proSP-C and GRP78
were similar in the three cell lines. These results indicate that
the expression of ABCA3 in A549 cells shifts the distribution
of LAMP3 but not that of proSP-C or GRP78 on the sucrose
density gradient.
Fig. 3. Sucrose gradient fractionation of intracellular compartments from mouse lung, A549, A549/ABCA3WT, and A549/ABCA3N 568D cells. A:
PNS (4 mg of protein) from mouse lung was fractionated in a sucrose gradient. Fractions 1 and 10 are the lowest and highest density fractions,
respectively. The contents of choline-phospholipids (closed circle) and total cholesterol (open circle) are shown. The inset shows nile red-staining of
fraction 3. The scale bar represents 2 lm. B: Immunoblot analysis shows the distribution of ABCA3, proSP-C, mature SP-C, and GRP78 in each
fraction. C: PNS (2 mg of protein) from A549 (left panel), A549/ABCA3WT (middle panel), and A549/ABCA3N568D cells (right panel) was
fractionated. The contents of choline-phospholipids (closed circle) and total cholesterol (open circle) are shown. The insets show nile red-staining of
fraction 3. The scale bar represents 2 lm. D: Immunoblot analysis shows the distribution of ABCA3-GFP, LAMP3, proSP-C, and GRP78 in each
fraction from A549 (left panel), A549/ABCA3WT (middle panel), and A549/ABCA3N568D cells (right panel). Experiments were performed three
times, and representative data are shown. E: Thin-layer chromatography analysis shows the lipid composition of fraction 3 in A549 and A549/
ABCA3WT cells. PE, phosphatidylethanolamine; PI, phosphatidylinositol; PC, phosphatidylcholine; SM, sphingomyelin; s.f., solvent front; ori.,
origin.
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lamellar structure in A549 cells
Electronmicroscopy was performed to analyze the ultra-
structure of intracellular vesicles in A549/ABCA3WT cells. In
mouse lung, mature lamellar bodies, which have a complete
lamellar structure, were observed (Fig. 4A). In A549/AB-
CA3WT cells, tightly packed multilamellar vesicles (approxi-
mately 1 lm) with an electron-dense core (Fig. 4B) and with
multiple small intravesicles (Fig. 4C), so-called growing lamel-
lar bodies [20], were observed. On the other hand, these multi-
lamellar vesicles were not observed in A549 and A549/ABCA3N568D cells (data not shown). These results suggest that
the expression of wild-type ABCA3-GFP promotes the growth
of lamellar structure in A549 cells.4. Discussion
In this study, to clarify the mechanism of lipid transport
mediated by ABCA3, GFP-tagged wild-type and N568D mu-
tant ABCA3, which exhibits impaired ATP-binding and
ATP-hydrolysis activities [10], were stably expressed in A549
Fig. 4. Ultrastructure of vesicles in A549/ABCA3WT cells. (A) Mature
lamellar body in mouse lung. (B,C) multilamellar vesicles in A549/
ABCA3WT cells. The scale bar represents 1 lm.
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ABCA3WT cells was higher than those in A549 and A549/AB-
CA3N568D cells (Fig. 2A), and that while low-density, nile-red
positive, and choline-phospholipids-rich vesicles were common
in A549/ABCA3WT cells, they were not seen at all in A549 cells
and seen rarely in A549/ABCA3N568D cells (Fig. 3C). In addi-
tion, the level of LAMP3 in A549/ABCA3WT cells was in-
creased compared to that in A549 and A549/ABCA3N568D
cells (Figs. 1A and 3D), Furthermore, the LAMP3-positive
organelles were larger than those in A549 and A549/AB-
CA3N568D cells (Fig. 1B), and a portion of LAMP3 was shifted
to lower-density fractions in the sucrose gradient (Fig. 3D).
Moreover, multilamellar vesicles were observed in A549/AB-
CA3WT cells. These results demonstrate for the ﬁrst time that
ABCA3 mediates ATP-dependent uptake of natural choline-
phospholipids into LAMP3-positive vesicles.
Fluorescence-labeled lipid analogs are powerful tools for
visualizing the movement of lipids in cells. Cheong et al.
showed that silencing ABCA3 with small interfering RNA re-
duced vesicular uptake of ﬂuorescence-labeled phosphatidyl-
choline, sphingomyelin, and cholesterol in human lung
alveolar type II cells [6]. However, in some cases, natural lipids
and ﬂuorescence-labeled lipid analogs are transported in a dif-
ferent manner within the cell [21,22]. Both approaches are
therefore required for precise determination of ABC trans-
porter-mediated lipid translocation.
Mature SP-B and SP-C, which localize within multivesicular
bodies and/or lamellar bodies, are important for surfactant
function. Mature SP-B is suggested to be important for con-
verting internal vesicles of multivesicular body to organized
lamellae [23], and SP-B knockout mice have immature lamellar
bodies that contain numerous internal vesicles with few mem-
brane lamellae [24,25]. On the other hand, mature SP-C is in-
volved in the formation and maintenance of surfactant ﬁlm at
the alveolar space but not in lamellar body formation, and SP-C knockout mice have impaired surfactant function and nor-
mal lamellar bodies [26]. We expected the expression of mature
SP-B and the formation of mature lamellar bodies in A549/
ABCA3WT cells because the ABCA3-positive vesicles in
A549 cells appeared to be larger than those in non-lung
HEK293 cells [10]. However, proSP-B but not mature SP-B
was detected (data not shown), and growing but not mature
lamellar bodies were observed in A549/ABCA3WT cells
(Fig. 4). Because ABCA3 is localized at the limiting membrane
of LAMP3-positive vesicles (Fig. 1B, panels d–f), ABCA3-
mediated choline-phospholipids uptake into vesicles, which
might be the result of lipid ﬂip-ﬂop from the cytosolic side
to the lumen side, is essential for the growth of lamellar struc-
ture, and mature SP-B as well as other unidentiﬁed proteins
may be required for the formation of fully organized lamellar
bodies.
Very recently, we and another group reported ABCA3
knockout mice data suggesting a critical role for ABCA3 in
the metabolism not only of phoshatidylcholine [27] but also
of phosphatidylglycerol [27,28], a secondary abundant lipid
among surfactant phospholipids [18]. Further studies are
needed to clarify the role of ABCA3 in phosphatidylglycerol
transport.
In summary, we have shown that ABCA3 mediates ATP-
dependent choline-phospholipids uptake into intracellular
LAMP3-positive vesicles in A549 cells. Our approach can be
applied not only to understanding the pathophysiology of lung
diseases of variable severity associated with ABCA3 mutations
[29,30] but also to determining the transport function of other
ABCA transporters involved in storage into intracellular com-
partments, such as ABCA12.
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